In vitro and in vivo evaluation of doxorubicin conjugates with the divalent peptide E-[c(RGDfK)2] that targets integrin alphavbeta3.
Ryppa, Claudia
In vitro and in vivo evaluation of doxorubicin conjugates with the divalent peptide E-[c(RGDfK)2] that targets integrin alphavbeta3. [electronic resource] - Bioconjugate chemistry Jul 2008 - 1414-22 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1520-4812
10.1021/bc800117r doi
Amino Acid Sequence
Animals
Cell Line, Tumor
Cell Proliferation--drug effects
Doxorubicin--metabolism
Endothelial Cells--cytology
Female
Humans
Integrin alphaVbeta3--metabolism
Mice
Oligopeptides--chemistry
Prodrugs--chemistry
In vitro and in vivo evaluation of doxorubicin conjugates with the divalent peptide E-[c(RGDfK)2] that targets integrin alphavbeta3. [electronic resource] - Bioconjugate chemistry Jul 2008 - 1414-22 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1520-4812
10.1021/bc800117r doi
Amino Acid Sequence
Animals
Cell Line, Tumor
Cell Proliferation--drug effects
Doxorubicin--metabolism
Endothelial Cells--cytology
Female
Humans
Integrin alphaVbeta3--metabolism
Mice
Oligopeptides--chemistry
Prodrugs--chemistry